Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by adamchesson Mar 29, 2016 2:24am
86 Views
Post# 24706714

RE:Sunshine

RE:SunshineFYI.. for what its worth, Peter van Teggelen is now CFO of CRF Health. Hard to tell if he left of his own accord. I am guessing he did for what ever reason.

https://www.crfhealth.com/leadership/


CH4RTQU4NT wrote: I try to stay unbiased so sell me on this CFO change which I view as a negative if only because I cringe when I hear the word "Nortel".  Do you know what the reasons for the previous CFOs departure were? 

Change of CFO at Concordia’s subsidiary, Amdipharm Mercury Limited (AMCo)

Adeel Ahmad, previously Concordia’s Vice President of Finance, has been promoted to Chief Financial Officer of AMCo. Concordia acquired AMCo in October 2015. Mr. Ahmad replaces Peter Van Tiggelen, who served as AMCo’s CFO fromSeptember 2013 to January 2016.   

“We’d like to thank Peter for helping us work through the initial integration of the two businesses,” said Mark Thompson, Concordia’s Chairman and Chief Executive Officer. “Moving ahead, we believe Adeel’s deep knowledge of Concordia’s North American operations, and the pharmaceutical sector in general, will help us maximize the international opportunity ahead of us as a result of the AMCo acquisition, and the integration of the two businesses.” 



<< Previous
Bullboard Posts
Next >>